---
title: "Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy"
date: 2021-01-01
sort_key: 2020836
paperurl: "https://doi.org/10.3390/cancers13194846"
---

MT Mouritzen, A Carus, M Ladekarl, P Meldgaard, AWM Nielsen, A Livbjerg, JW Larsen, H Skuladottir, C Kristiansen, K Wedervang, T Schytte, KH Hansen, A-C Østby, MS Frank, J Lauritsen, JB Sørensen, SW Langer, GF Persson, JL Andersen, JMC Frary, LB Drivsholm, C Vesteghem, **HS Christensen**, B Bjørnhart & M Pøhl (2021). "Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy." *Cancers*.
